Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.


There are currently no effective, long-term drug therapies for the treatment of leiomyomas. Pirfenidone (Marnac, Inc.) is an antifibrotic agent that is being tested for use in patients with pulmonary fibrosis. Because leiomyomas are characterized also by increased cell proliferation and tissue fibrosis, we examined the effects of pirfenidone on cell… (More)

6 Figures and Tables


  • Presentations referencing similar topics